Enzyme PapB Boosts Drug Longevity

By Bridgette Jacobs

Scientists have identified an enzyme, PapB, that can reshape fragile drug molecules into durable, ring-shaped structures, significantly enhancing the longevity and effectiveness of peptide-based medications like Ozempic. This breakthrough offers a simpler and more precise method for drug modification, paving the way for stronger and longer-lasting treatments across various health conditions.

Researchers have identified an enzyme, PapB, which can reshape fragile drug molecules into more durable, ring-shaped structures.
This breakthrough, as reported by ScienceDaily, holds the potential to significantly enhance the longevity and effectiveness of peptide-based medications.
Medications such as Ozempic and Wegovy, currently used for diabetes and obesity, are examples of treatments that could be improved by this discovery.
According to ScienceDaily, the enzyme offers a simpler and more precise method for drug modification compared to existing techniques.
This novel approach could ultimately lead to the development of stronger and longer-lasting treatments for various health conditions.

Reporting Sources 1